A year long collaborative feasibility study working with a government agency has been concluded to demonstrate the successful application of the Glide technology. The feasibility study, in the area of bio-defence, demonstrated non inferiority of the solid delivery to the needle and syringe injection of the liquid formulation. Discussions are ongoing to investigate stability and dose sparing potential.
